Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

Front Pharmacol. 2021 Oct 4:12:774792. doi: 10.3389/fphar.2021.774792. eCollection 2021.

Authors

Dan Huang^{1

2}, Xindong Wang^{1

2}, Yunhong Zhu^{1

2}, Juexiao Gong^{1

2}, Junqing Liang³, Yanfei Song³, Yiyan Zhang^{1

2}, Linsheng Liu⁴, Cong Wei³

Affiliations

¹ Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
² Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
³ National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Shijiazhuang, China.
⁴ Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.658998.].

Keywords: GPER1 antagonist; apoptosis; atherosclerosis; bazi bushen capsule; inflammation; lipid profile.

Copyright © 2021 Huang, Wang, Zhu, Gong, Liang, Song, Zhang, Liu and Wei.

Publication types

Published Erratum